Panagora Asset Management Inc Nuvasive Inc Transaction History

Panagora Asset Management Inc

$19.1 Billion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$35.68 - $44.71 $2.38 Million - $2.98 Million	66,564 Added 181.65%	103,209 $4.26 Million
Q3 2022 Nov 14, 2022	BUY	$42.51 - $54.02 $340,335 - $432,484	8,006 Added 27.95%	36,645 $1.61 Million
Q2 2022 Aug 15, 2022	BUY	$46.84 - $59.75 $6,932 - $8,843	148 Added 0.52%	28,639 $1.41 Million
Q1 2022 May 12, 2022	SELL	$48.09 - $57.79 $5,722 - $6,877	-119 Reduced 0.42%	28,491 $1.62 Million
Q4 2021 Feb 10, 2022	SELL	$47.19 - $62.68 $29,965 - $39,801	-635 Reduced 2.17%	28,610 $1.5 Million

Q3 2021 Nov 10, 2021	BUY	$56.91 - $67.81 $1.66 Million - $1.97 Million	29,100 Added 20068.97%	29,245 $1.75 Million
Q2 2021 Aug 11, 2021	SELL	$64.02 - $71.72 $84,378 - $94,526	-1,318 Reduced 90.09%	145 $10,000
Q4 2020 Feb 10, 2021	SELL	$43.41 - $56.51 $764,971 - $995,819	-17,622 Reduced 92.33%	1,463 $82,000
Q3 2020 Nov 13, 2020	SELL	$47.43 - $60.75 $2.86 Million - $3.66 Million	-60,269 Reduced 75.95%	19,085 $927,000
Q2 2020 Aug 12, 2020	SELL	$43.51 - $66.59 $2.65 Million - $4.06 Million	-60,916 Reduced 43.43%	79,354 $4.42 Million
Q1 2020 May 14, 2020	SELL	$32.82 - $81.13 $2.31 Million - $5.71 Million	-70,412 Reduced 33.42%	140,270 $7.11 Million
Q4 2019 Feb 12, 2020	BUY	$60.96 - $77.7 $8.22 Million - $10.5 Million	134,904 Added 178.03%	210,682 $16.3 Million
Q3 2019 Nov 12, 2019	BUY	$55.78 - $68.08 $3.99 Million - $4.87 Million	71,552 Added 1693.14%	75,778 $4.8 Million
Q1 2019 May 15, 2019	BUY	$44.53 - $58.9 $181,949 - $240,665	4,086 Added 2918.57%	4,226 $240,000
Q1 2018 May 15, 2018	BUY	$46.03 - $61.28 $6,444 - $8,579	140 New	140 $7,000

Others Institutions Holding NUVA

# of Institutions

Shares Held

116K

Call Options Held

Put Options Held

View Full List

About NUVASIVE INC

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

More about NUVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account